Table 2.
Susceptibility rate to other AB of MRSA vs. MSSA isolated from ocular infections [6]
| Eye infections overall n (% susceptibility) | conjunctivitis n (% susceptibility) | keratitis n (% susceptibility) | |
|---|---|---|---|
| Ciprofloxacin | |||
| MSSA | 604 (87.4%) | 164 (89.4%) | 144 (79.8%) |
| MRSA | 416 (27.9%) | 108 (20.7%) | 93 (5.2%) |
| Total | 1020 | 272 | 237 |
| Gentamicin / Tobramycin | |||
| MSSA | 604 (98.5%) | 164 (97.6%) | 144 (98.6%) |
| MRSA | 416 (90.9%) | 109 (87.9%) | 93 (88.3%) |
| Moxifloxacin | |||
| MSSA | 312 (89%) | 106 (89.4%) | 86 (81%) |
| MRSA | 375 (23.8%) | 103 (20.4%) | 86 (5.7%) |
| Total | 687 | ||
| Levofloxacin | |||
| MSSA | 604 (89.1%) | 164 (91.8%) | 144 (84%) |
| MRSA | 416 (27.9%) | 108 (22.5%) | 93 (5.2%) |
| Total | 1020 | ||
| Vancomycin | |||
| MSSA | 604 (99%) | 164 (99%) | 144 (98%) |
| MRSA | 416 (97%) | 109 (96%) | 93 (98%) |
| Total | 1020 | ||
| % MRSA | 40.8% | 39.9% | 39.2% |